ClearanceBrief
Recall Z-0138-2022 ยท LNH System, Nuclear Magnetic Resonance Imaging

GE Healthcare, LLC

SIGNA Voyager nuclear magnetic resonance imaging system

DateOct 16, 2021 (initiated Aug 26, 2021)
StatusTerminated
ReasonUnder certain conditions, some slices may be missing which can lead to a gap of anatomy in the 3D Volume images.
Root causeSoftware design
ActionGE issued an Urgent Medical Device Correction letter to customers with affected devices. This letter informs the customer of the issue and provides safety instructions for the continued use of the device. GE Healthcare will correct all affected devices at no cost to the customer. In the U.S., this letter will be sent by a traceable means. This letter will be sent to the following titles within the affected accounts: Director of Clinical/Radiology, Risk Manager/Hospital Administrator.
Quantity15 devices
DistributionDistribution in United States to AZ, CA, FL, GA, IL, LA, MA, MD, MN, NC, NH, NJ, NY, OH, OK, TX, VA, WA, and Puerto Rico OUS distribution to: Australia, Belgium, Canada, Chile, Colombia, France, Germany, Italy, Japan, Korea, Poland, Saudi Arabia, Spain, Sweden, Turkey, UAE, and UK
FDA recordOpen on fda.gov

510(k) clearances named in this recall

K161567SIGNA Voyager
GE Healthcare, Sep 1, 2016
K192426Signa Voyager, Signa Voyager Quantum
Ge Healthcare (Tianjin) Company Limited, Oct 1, 2019